The CFO departure is sudden and effective immediately, but the stated reason (personal considerations) and the immediate appointment of a qualified replacement reduce concern. Monitor the November 12, 2026 reconvened special meeting for the charter amendment vote outcome, which could affect governance and potential financing flexibility.
Price Chart
Executive Summary
Tempest Therapeutics CFO Constance Ames resigned effective immediately on October 26, 2026 for personal reasons. The board appointed Stephanie Horn-Warnock as CFO, principal financial and accounting officer, treasurer, and corporate secretary, effective the same day. Horn-Warnock will serve as a consultant at $450 per hour plus expenses and a 5% indirect cost allocation.
Key Facts
- CFO Constance Ames resigned effective October 26, 2026 for personal considerations unrelated to the company
- Stephanie Horn-Warnock appointed as CFO, Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary effective October 26, 2026
- Horn-Warnock will serve as a consultant at $450 per hour plus expenses and 5% indirect cost allocation
- Horn-Warnock is a CPA with 14+ years experience, most recently in financial leadership roles through Stout Risius Ross, LLC
- The filing follows a DEFA14A from October 20, 2026 reporting an adjourned special meeting due to insufficient votes for a charter amendment
Financial Impact
CFO compensation at $450/hour consulting rate; no equity or severance disclosed
Risk Factors
- Sudden CFO resignation without transition period could indicate undisclosed issues
- Consulting arrangement for CFO role may signal temporary or interim nature of appointment
- Ongoing governance uncertainty from failed charter amendment vote may complicate capital raising
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-114376 |
| Document: 0001213900-26-114376-index-headers.html | 0001213900-26-114376 |
| Document: 0001213900-26-114376-index.html | 0001213900-26-114376 |
| Document: 0001213900-26-114376.txt | 0001213900-26-114376 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | 8-K | $0.5333 | awaiting T+20 | awaiting T+20 | $0.4960 (−6.99%) |
Oct 26, 2026 6d ago | DEF 14A | $0.5107 | awaiting T+20 | awaiting T+20 | $0.4960 (+2.88%) |
Oct 20, 2026 12d ago | DEFA14A | $0.5282 | awaiting T+20 | awaiting T+20 | $0.4960 (−6.10%) |
Oct 20, 2026 12d ago | 8-K | $0.5282 | awaiting T+20 | awaiting T+20 | $0.4960 (−6.10%) |
Oct 19, 2026 13d ago | 8-K | $0.5762 | awaiting T+20 | awaiting T+20 | $0.4960 (−13.92%) |
Oct 2, 2026 4w ago | EFFECT | $0.8112 $0.4955 | ▲ +38.92% | ▲ +37.11% | $0.4960 (+38.86%) |
Sep 25, 2026 5w ago | S-3 | $0.8316 $0.5102 | ▲ +38.65% | ▲ +38.62% | $0.4960 (+40.36%) |
Sep 17, 2026 6w ago | 8-K | $0.9680 $0.6240 | ▼ −35.54% | ▼ −35.74% | $0.4960 (−48.76%) |
Sep 16, 2026 6w ago | DEFA14A | $0.8950 $0.6350 | ▼ −29.05% | ▼ −30.51% | $0.4960 (−44.58%) |
Sep 16, 2026 6w ago | 8-K | $0.8950 $0.6350 | ▼ −29.05% | ▼ −30.51% | $0.4960 (−44.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers